Bayer, defended by Herbert Smith Freehills, said the McNickle judgment was the first Roundup final judgment outside the U.S.

Germany is widely recognized as one of the leading countries in the pharmaceutical industry boasting a rich history of innovation cutting-edge research and global influence With its well-established i ...

Elanco Animal Health is making progress on debt repayment, new product approvals, and launches. Learn why ELAN stock is a Buy ...

Advocates for small communities in Iowa are calling on state lawmakers not to pass the so-called "Cancer Gag Act," which they ...

advancements in companion animal and livestock health; and diverse synthetic biology applications such as producing enzymes, biofuels and chemicals. Current licensees include GSK, Merck, Bayer ...

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...

Bayer expects its pharmaceutical business to return to growth in 2027 as the launch new therapies is expected to offset ...

Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the ...

Growth is on the horizon for German drug conglomerate Bayer (BAYRY), despite “falling sales of its blockbuster blood thinner Xarelto,”amid ...

German consumer sentiment tumbles on job cut fears, survey shows European Marketscategory· November 27, 2024 Bayer on Tuesday struck a collaboration deal with U.S. biotech firm Cytokinetics to ...